Bioanalytical Strategies for New Modalities - Part 2

Moderator(s)

• 

  Linlin Luo, Dr. (she/her/hers)

  Sr. Director
  Merck & Co., Inc.
  West Point,, Pennsylvania

Presentations:

• 1:35 PM – 2:05 PM CST

  Cell-Based Therapies: Adaptations and Considerations for Global Bioanalysis
  

  Speaker: Thanh-Long Nguyen, PhD (he/him/his) – ICON plc
• 2:05 PM – 2:35 PM CST

  Leveraging Learnings from Ligand-Binding and LCMS Methodologies for ARC Bioanalysis
  

  Speaker: Catherine L. Brockus, PhD (she/her/hers) – Eli Lilly and Company
• 2:35 PM – 3:05 PM CST

  Enhancing Cellular Immunogenicity Assessment Through Elispot Testing: Leveraging Advances and Resources
  

  Speaker: Sylvia Janetzki, MD (she/her/hers) – ZellNet Consulting, Inc.